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Abstract
The scientific community has learned a great deal from imaging small and naturally transparent 
organisms such as nematodes and zebrafish. The consequences of genetic mutations on their organ 
development and survival can be visualized easily and with high-throughput at the organism-wide 
scale. In contrast, three-dimensional information is less accessible in mammalian subjects because 
the heterogeneity of light-scattering tissue elements renders their organs opaque. Likewise, 
genetically labeling desired circuits across mammalian bodies is prohibitively slow and costly via 
the transgenic route. Emerging breakthroughs in viral vector engineering, genome editing tools, 
and tissue clearing can render larger opaque organisms genetically tractable and transparent for 
whole-organ cell phenotyping, tract tracing and imaging at depth.
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Introduction – The case for a hermeneutic approach to biological 
investigation
From slime mold to the rhesus macaque, countless species have contributed to our current 
understanding of the biological processes that grant life. The optimum animal model for a 
line of research is often determined by a particular anatomical feature that makes the 
organism uniquely suitable for experimentation. For example, although the giant squid may 
seem an unusual choice to further understanding of mammalian neural circuits, the sheer 
size and slow conduction velocity of its axons enabled scientists to study neuronal firing 
with the rudimentary electrophysiological techniques available during the early 20th century 
[1], giving rise to the field of modern cellular neuroscience. By examining individual aspects 
of a diverse range of organisms in great detail, scientists have been able to amass a set of 
unifying principles for the field of neural sciences [2]. The route to this understanding 
parallels the hermeneutic circle, a classic concept in theology and logic [3]. In hermeneutics, 
the process of interpretation follows a spiraling path in which one first studies the overall 
body, then examines its composite parts, and lastly revisits the concept of the whole body as 
a sum of the parts. Similarly, in neuroscience, observation of a particular sensory or motor 
system in an organism leads to investigation of the cellular underpinnings of the related 
circuits, which are then placed in the larger context of the central and peripheral nervous 
systems.
Applying this approach to investigations of molecular and cellular physiology in health and 
disease (Table 1, first column) can be both technologically challenging and time-consuming 
in mammalian subjects. Mammalian tissues can be easily photographed at the macroscopic 
level, and then the organs and tissues can be dissected and thinly sliced for microscopic 
analysis. However, the process of aligning these two different perspectives to reconstruct a 
whole-organism map with subcellular resolution remains nontrivial [4]. Without a clear 
methodology for integrating microscale and macroscale views, it is difficult to apply newly-
discovered molecular mechanisms to systems-level questions and to recognize how systems-
level findings may in turn inform novel hypotheses on molecular processes.
Two recent technical advances can bridge the divide between cellular and systems-level 
studies (Table 1). First, improved viral-vector-based strategies can deliver cargo, such as 
fluorescent labels, efficiently and with cell specificity over entire organs or the whole body. 
This enables tracing of, for example, wide-coverage brain networks or peripheral nerves ([5–
14], reviews: [15–20]). Second, optimized tissue-clearing methodologies (Table 2–3) can 
map intact local and long-range circuits [21–41]. The former merges two powerful 
biological techniques: the use of genetically encoded tools for studying cellular function and 
connectivity, and the development of viral vectors as a vehicle for delivering these tools into 
cells [10,11,13,19,42–54]. The latter illustrates how the century-old technique [55,56] of 
tissue clearing may gain renewed importance when it is refined to incorporate current 
advances in microscopy [27,29,57–61], genetically encoded fluorescent labeling tools 
[7,8,14,62–66], protein affinity tags [67–71], and tissue-binding size-adjustable polymeric 
scaffolding [22,29,32,37,41,72,73]. This brief review will highlight recent work on 
generating adeno-associated viruses with unique properties via specialized viral-vector 
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screening methods [53,74–80] (Figure 1, Box 1), and on modern tissue-clearing 
methodologies that preserve fluorescence and support high-resolution imaging at depth 
(Figure 2, Table 2, and Box 1; the following protocols generally achieve both goals: [21–
25,28,29,31,32,35–37,39–41,81–83] and uDISCO, which outperforms 3DISCO in 
fluorescence preservation, personal communication with Dr. Ali Ertürk).
Scientific motivation for broad coverage gene delivery and imaging of 
whole intact tissues in mammals by tissue clearing
Although viral vectors are commonly used for delivering genetically encoded cargo to 
mammalian cells in vivo, therefore avoiding slow and costly transgenic means, few are 
capable of both safe and efficient transduction of specific cellular targets. Fewer still are 
capable of broad coverage across all cellular connectivity under study. For example, adeno-
associated viruses (AAVs) are widely used, especially in non-dividing cells, due to their 
safety [78,84–86]; however, the handful of serotypes available cannot efficiently and 
specifically target many populations of interest. Past and ongoing efforts on engineering 
viral vectors with desired properties [79,87,88], including cell-type and/or organ specificity 
[74–77,79,89], will greatly benefit research in mapping and genome editing [90]. To 
contribute to and complement these efforts we have recently developed an in vivo Cre-
REcombination-based AAV Targeted Evolution (CREATE) selection platform for 
identifying AAVs that more efficiently transduce genetically defined cell populations (Figure 
1A) [53]. We used CREATE to identify variants from a systemically delivered AAV capsid 
library that cross the blood–brain barrier and transduce neurons and astrocytes brain-wide. 
Using this method, we identified one variant, AAV-PHP.B1, that achieves 40- to 90-fold 
more efficient brain-wide transduction than the current standard, AAV9 (Figure 1D) [91]. 
AAV-PHP.B transduces most neuronal types and glia throughout the brain, which supports 
its use to deliver multicolor labels to genetically defined circuits for mapping distributed 
networks, such as those recruited by deep brain stimulation [92–97]. Furthermore, 
engineered vectors that label discrete cell populations could be put to immediate use, for 
example in elucidating points of contact between major somatic sensory nerves and the 
CNS, or in mapping the autonomic motor branch of the PNS to better understand metabolic 
and endocrine disorders.
Despite these new labeling technologies, it remains difficult to create maps for 
phenotypically distinct fine axons that run in bundles throughout the brain when the 
traditional method involves sectioning the tissue into paper-thin slices, imaging each slice, 
and recovering the 3D perspective with imaging software: it is slow, tedious, costly, and 
error prone. Over the past decade there has been a surge in methods for increasing the 
transparency of thick mammalian tissue samples and whole organs so that they may be 
examined intact (Table 2). Here, the scientific value of fluorescence-preserving tissue 
clearing for vector engineering is also apparent: the ability to process major organs 
simultaneously and without sectioning (Figure 1B–C) will greatly facilitate transduction 
1Novel AAV capsid: AAV-PHP.B was named in honor of Caltech Professor Paul H. Patterson (1943–2014).
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mapping of systemically delivered genes (Figure 1D), including small-molecule tags and 
fluorescent labels.
Whole-organ and whole-body tissue-clearing methodologies
The original century-old tissue-clearing techniques [55,56] enable deep imaging into tissue 
without physical sectioning, but the harsh organic solvents damage cellular architecture and 
are incompatible with modern immunolabeling and fluorescence microscopy tools. Thus, the 
application of modern labeling technologies to ex vivo mapping studies requires new 
developments to render tissues transparent while also stabilizing critical macromolecules 
and preserving endogenous fluorescence (see Table 2 for a comprehensive list of major 
clearing protocols of the last decade). In particular, the CLARITY technique provides a 
method to further stabilize samples by anchoring tissue components in place using an 
interpolating hydrogel scaffold [22,37]. This transparent, tissue-binding hydrogel mesh 
secures proteins and nucleic acids into place without causing epitope masking and allows 
scientists to visualize intact organs at the subcellular [40,41] and even single transcript scale 
[22,29,32,37,41]. Recently, a method to clear whole adult rodents and organs emerged from 
the realization that hydrogel monomers as well as clearing detergents and immunolabeling 
reagents could all be infused throughout the intact post-mortem organism using the intrinsic 
circulatory system (vasculature) (Figure 1B–C, Figure 2A–B) [32,41]; PARS (Perfusion-
assisted Agent Release in Situ) achieves delipidation and labeling steps rapidly in the intact 
post-mortem organism via perfusion. The PARS approach, which has also proven 
compatible with a variety of tissue-clearing reagents [25,31,39,40], can prepare transparent 
whole organisms for imaging at depth and aligns with a paradigm shift in biomedical 
research. Namely, efforts to profile the two-dimensional molecular content of samples have 
been superseded by more comprehensive inquiries into the relationship between an organ’s 
volumetric composition and its resulting biological function [98].
Across most disciplines and within a variety of laboratory settings, it has become 
increasingly relevant to engage in the fine-scale phenotyping of whole specimens, whether 
of intact samples, such as tissue biopsies, excised organs and cultured organs in a dish 
[99,100], or of whole organisms. Thus, tissue clearing methods must be simple, economical 
and adaptable to a variety of applications to be adopted across scientific fields. Toward this 
goal, we developed a set of hydrogel-embedding and delipidation protocols that can be used 
to rapidly clear excised organs individually or all organs simultaneously within the intact 
body without compromising cellular architecture or endogenous fluorescence (for 
experimental timeline and details, see Tables 2–3; for troubleshooting advice, see: http://
www.nature.com/nprot/journal/v10/n11/fig_tab/nprot.2015.122_T5.html) [32,41]. PACT 
(PAssive CLARITY Technique) and PARS entail hybridizing the tissue sample to polymers 
in order to anchor proteins and nucleic acids during detergent-mediated lipid extraction and 
to preserve gross tissue architecture during all tissue-processing steps (Figure 1B–C, Figure 
2A–B) [32,41]. While many clearing protocols are successful at removing lipids through 
detergent treatment alone, we have found that the porous structure of the tissue–hydrogel 
matrix, particularly when coupled to the driving force of detergent perfusion, facilitates 
rapid diffusion of solubilized lipids out of the tissue and the subsequent penetration of 
immunolabels into the remaining tissue–hydrogel matrix. Furthermore, the utility of tissue-
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hydrogel hybridization and detergent perfusion extends beyond their capacity to facilitate 
rodent organ and whole-body clearing and immunolabeling [32,41]. For example, hydrogel 
embedding effectively stabilizes amorphous or fragile samples [41], such as sputum 
(unpublished results), for processing, and secures microorganisms to sites of infection. This 
latter property has proven valuable in studying bacterial colonization (personal 
communication with Dianne Newman). Although originally demonstrated in whole rodents, 
perfusion-based methods may also render large, excised samples such as primate and pig 
organs transparent via the recirculation of PARS reagents through catheterized organ 
vasculature [101], an undertaking which would be prohibitively slow via passive immersion-
based clearing. Finally, after initial lipid extraction and/or solvation steps (Table 2, chemical 
clearing), most tissue-clearing protocols employ a refractive-index homogenization step to 
minimize differences in light deflection by the heterogeneous tissue biomolecules (Table 3, 
optical clearing). This is most commonly accomplished via immersing chemically cleared 
samples in a solution of matched refractive index, such as RIMS (Figure 2A) [32,41]; polyol 
and concentrated sugar or sugar alcohol solutions such as glycerol [22], sucrose and fructose 
[21,24,39,102]; or organic solvents such as BABB [27,28,82] and others (see Table 3).
The ability to expediently process and analyze samples without sectioning has 
revolutionized modern histology. For example, tissue clearing allows pathologists to map 
tumor cells in whole human biopsies and postmortem samples [41]. Likewise, the ability to 
conduct fast whole-body clearing, as granted by the perfusive force in the PARS 
methodology [39], opens new avenues for exploring small-molecule biodistribution, 
examining viral-vector tropism (Figure 1), and tracing peripheral nerve networks to their 
target organs (Table 1) [31,32,39,41]. For difficult-to-clear bone samples, PACT with 
decalcification (PACT-deCAL [41]), SeeDB [103], 3DISCO [28], Murray’s clear (1:2 
Benzyl Alcohol: Benzyl Benzoate; BABB [27]) [104] and other decalcification methods 
[105] all facilitate mapping the three-dimensional architecture of skeletal tissue and stem 
cell niches [106]. Regardless of the clearing protocol used, all carry trade-offs in terms of the 
degree of optical transparency achieved, the maintenance of endogenous fluorescence, the 
preservation of cellular integrity, and the permeability of cleared tissue to macromolecule 
labels. Although clearing with organic solvents or with electrophoresis may deliver more 
rapid and effective clearing than passive methods involving immersion in aqueous solutions, 
these harsher methods may also hinder fluorescent imaging, prove incompatible with 
immunolabeling, or risk tissue damage (see Table 2). In selecting a specific protocol or 
shuffling aspects of multiple protocols [107], researchers must consider their project 
objectives (e.g., imaging sparse epitopes, whole-body tract tracing) and experimental 
constraints (e.g., integration with smFISH or electron microscopy studies on cleared 
samples). Thus, this comprehensive list of available protocols (Tables 2–3) will serve most 
experimental needs (Table 1).
Towards structure–function mapping with tissue clearing
For tissue-clearing methods to reach their full potential, several major challenges must first 
be tackled: (1) Imaging: large tissue volumes require specialized microscopy; (2) Data 
analysis: meaningful data must be extracted from terabyte data sets; (3) Access to functional 
information: markers of activity must be preserved during tissue processing.
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Regarding the extraction of functional information, a record of neuronal activity can be 
encoded via transcriptional or biochemical changes. For example, immediate-early-gene 
activation (e.g. through Targeted Recombination in Active Populations, or TRAP [108–
111]), Ca2+ influx, and voltage spikes can all be detected by genetically encoded fluorescing 
sensors (for reviews, see [112–114]) [53,111,115–118]. An exciting possibility for resolving 
neuronal activation across longer timescales is to pair this in vivo activity sensing with ex 
vivo analysis of previously active cell circuits using thick-tissue clearing. Specifically, 
genetically encoded stable fluorescent markers can permanently tag living cells that respond 
to time-restricted stimuli so that their chemical identity and connectivity can be probed post-
mortem. One such marker, CaMPARI (calcium-modulated photoactivatable ratiometric 
integrator of neuronal activity), grants persistent quantitative detection of any neuronal 
activity that occurs during subsecond application of the photoconversion light [64,119]. One 
can envision the combined use of CaMPARI with subsequent tissue-clearing methods that 
preserve endogenous fluorescence (such as ScaleS [40] clearing and RIMS incubation 
[32,41]) to map the activity of intact biological networks in response to behaviorally relevant 
stimuli.
As we learn more about the transcriptional correlates of neuronal activity, quantitative and 
multiplexed RNA detection in intact tissue could also serve the role of extracting functional 
proxies from deceased tissue. Combinatorial labeling (“barcoding”) via single-molecule 
fluorescence in situ hybridization (smFISH) [120,121] allows for simultaneous detection of 
mRNA transcripts for multiple genes within individual cells [122,123]. Importantly, smFISH 
has been validated in thick sections, wherein tissue clearing and swelling improve single-
transcript resolution through reducing background and physically separating single-molecule 
labels [32,122]. Further enlargement of the optical space within a cell, either for 
fluorescently barcoding multiple transcripts or for examining single-cell morphology, may 
be achieved through recent protocols (e.g. ExM [72], ePACT [41]) that expand tissue four-
fold or more with the possibility to retain endogenous fluorescence (Figure 2C–D for 
ePACT; [41]). Combined, these evolving technologies raise the possibility of single-cell 
transcriptomics with preserved spatial information. By applying high-resolution microscopy 
[58–60,124] to the detection of mRNA-binding probes (e.g., single-molecule hybridization 
chain reaction (smHCR) probes with high signal-to-noise [125–127]) in cleared and, if 
needed, expanded tissue, scientists will be able to achieve more robust single-molecule RNA 
detection and hence quantitative data for transcriptional profiling of intact circuits across 
organs [122,123,128].
Outlook
Studies in naturally transparent organisms have recently progressed to real-time monitoring 
of neuronal activity during controlled behavior via light-gated and light-emitting tools 
[118,129]. Although the protocols for tissue stabilization and lipid removal described above 
can produce samples with sufficient transparency for intact tissue imaging and rapid tissue 
phenotyping, these methods are limited to ex vivo use. Transparent or not, deceased tissue 
can offer only a static picture of neuronal connections. Even with a connectome in hand as a 
road-map for cellular networks, we would still be far from understanding the brain. For 
example, neuropeptides can act at a distance disregarding explicit wiring [130–132], parallel 
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pathways within a network can result in degeneracy in circuit function [133], and apparent 
structural connectivity (e.g. as elucidated via GRASP [134]) does not imply active synaptic 
connectivity [135]. A crucial next step will involve registering the three-dimensional 
information obtained through tissue-clearing with either ex vivo or in vivo cellular activity 
mapping. Compatible with cleared tissue imaging, methods such as TRAP [108–111] and 
smFISH [32,122] enable the permanent tagging of recently active cells in thick tissues. This 
snapshot only captures a single time point, however. What remains to be developed is a 
method for time-stamping signaling events across bulk cell populations such that the time-
varying metabolic information from a single-cell’s lifetime can be retrieved and cross-
correlated to the metabolic records of all neighboring cells. To this end, single-cell 
transcriptomics [136,137] and ‘molecular ticker tapes’ (i.e. an engineered DNA polymerase 
mis-incorporates nucleotides into a DNA 'ticker tape' based on spikes in ion concentration 
[138,139]) represent two areas of promise.
A second approach under development aims to bring the CLARITY concept to living tissue. 
Namely, instead of altering tissue to reduce light-scattering, scientists are recruiting the 
power of ultrasound focusing at depth to deliver and collect light non-invasively from living 
tissue. Methods such as Time-Reversal Ultrasound-Encoded (TRUE) aim to correct the 
light-wavefront in scattering tissue [140] and currently enable focusing at depth within ex 
vivo tissue [141,142]. Because of its high sensitivity to motion, challenges remain in using 
TRUE for noninvasive deep-tissue imaging and light delivery in vivo [143]. One possibility 
is to combine advances in optical imaging, such as TRUE, with the application of gentle 
tissue clearing reagents in vivo to decrease autofluorescent background and homogenize the 
refractive index [144,145].
Bringing “clarity” to living tissue, when combined with developments in labeling, imaging, 
and computation, will enable mapping of anatomical and functional connectivity and will 
illuminate the workings of intact circuits with high temporal precision. Although whole-
body imaging is still a nascent technology, analysis of the resulting volumetric datasets will 
convey a level of scientific understanding that cannot be replicated in a two-dimensional 
context; akin to previous work in the nematode and zebrafish, large-scale tissue clearing 
represents a first step towards a hermeneutic approach to mammalian biology.
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Box 1. Glossary of acronyms and terminology related to tissue-clearing and 
cell-mapping
3DISCO: Three-Dimensional Imaging of Solvent-Cleared Organs; 3DISCO and uDISCO versions.
AAV: Adeno-Associated Virus; multiple natural and non-natural serotypes, including AAV-PHP.B.
BABB: Benzyl Alcohol and Benzyl Benzoate; BABB and Murray’s Clear techniques.
Brainbow: stochastic expression of multiple fluorescent proteins from a single transgene; Brainbow v1.0–3.2 in 
addition to other variants (e.g.,
Autobow, Flybow, Zebrabow, R26R–Confetti, MAGIC Marker).
CaMPARI: Calcium-Modulated PhotoActivatable Ratiometric Integrator of neuronal activity
CLARITY: Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging/immunostaining/in situ 
hybridization-compatible Tissue hYdrogel;
CLARITY, advanced CLARITY, passive CLARITY, and stochastic-electrotransport versions.
CREATE: Cre-recombination-based AAV Targeted Evolution
CUBIC: Clear Unobstructed Brain Imaging cocktails and Computational analysis; CUBIC, advanced CUBIC 
and perfusion-CB variations.
Clear: a formamide-based optical clearing method; ClearT and ClearT2 (formamide/polyethylene glycol) 
variation.
DMSO: dimethyl sulfoxide
EDTA:ethylenediaminetetraacetic acid
ETC: Electrophoretic Tissue Clearing; clearing approach of CLARITY.
ePACT: expansion-PACT
ExM: Expansion Microscopy
Fruit: optical clearing method that utilizes an aqueous cocktail of fructose, urea, and α-thioglycerol.
GRASP: GFP Reconstitution Across Synaptic Partners
HCR: Hybridization Chain Reaction; operable with RNA and DNA probes
iDISCO: Immunolabeling-enabled 3D Imaging of Solvent-Cleared Organs; iDISCO and iDISCO+ variation.
IHC: Immunohistochemistry
NPS: Neuronal Positioning System
PACT: PAssive Clarity Technique
PACT-deCAL: PACT-deCALcification
PARS: Perfusion-assisted Agent Release in Situ ; PARS and PARS-CSF variation.
PFA: Paraformaldehyde
RI: refractive index
RIMS: Refractive Index Matching Solution; RIMS (histodenz-based) and sRIMS (sorbitol-based) variation.
Scale: a urea-based optical clearing method; ScaleA2 and ScaleU2 versions.
ScaleS: a sorbitol-based optical clearing method; includes AbScale, Chemscale, and ScaleSQ variations.
SDS: sodium dodecyl sulfate
SeeDB: See Deep Brain; SeeDB, SeeDB37 and SeeDB37ht variations.
smFISH: single-molecule Fluorescence In Situ Hybridization
Spalteholz’s preparation: Benzyl benzoate and methyl salicylate
SWITCH: System-Wde control of Interaction Time and kinetics of CHemicals
TDE: 2,2’-thiodiethanol
Tissue-Hydrogel: tissue structure and/or molecular content may be stabilized via tissue-hydrogel crosslinking 
or embedding; multiple hydrogel
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formulations, including any/all of acrylamide, bisacrylamide, paraformaldehyde, glutaraldehyde, sodium 
acrylate, agarose.
TRAP: Targeted Recombination in Active Populations
TRIO: ‘Tracing the Relationship between Input and Output’ method; TRIO and cTRIO methods.
TRUE: Time-Reversal Ultrasound-Encoded
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Highlights
1. Tissue clearing and viral vectors for resolved 3D imaging of unsevered 
circuits
2. Size-adjustable tissue-hydrogels for sample stabilization and selective 
extraction
3. Whole-body clearing and labeling via Perfusion-assisted Agent Release 
in Situ
4. High-throughput method for in vivo vector selection and bodywide 
transduction mapping
5. AVV vector for transgene expression brainwide via systemic injection 
in the adult
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Figure 1. 
Concept for an in vivo selection technology for panning large-scale libraries to identify 
compounds or biologicals with optimized physiological properties. Whole-body tissue 
clearing can then facilitate biodistribution mapping. For example, to engineer viral vectors 
for more effective transgene delivery, one strategy involves exposing live cells or whole-
organisms to AAV capsid libraries and then identifying positive hits via a cell or tissue type-
dependent recovery strategy (A). Whole-body clearing by Perfusion-Assisted Agent Release 
in Situ (PARS, [32,41]) speeds up the multi-organ assessment of vector variants expression 
Treweek and Gradinaru Page 23
Curr Opin Biotechnol. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
profiles. Internal organs before and after clearing (B). Individual PARS-cleared organs (C) 
before (top) or after (bottom) equilibration in RIMS, a Refractive Index Matching Solution 
[32,41], as imaging media. Black pointers correspond to the adrenal gland on the kidney, and 
to the ovaries on the fallopian tubes. Each square represents 0.5 cm2. The qualitative 
assessment of cell-type transduction can be conducted by packaging fluorescent reporters in 
individual capsid variants and then simultaneously clearing all organs in situ (D). As proof-
of-principle, a novel capsid variant (AAV-PHP.B, bottom), selected for enhanced brain 
transduction, was rapidly evolved from AAV9 (top). Comparisons of PARS-cleared organs 
demonstrate that AAV-PHP.B and AAV9 have similar cellular tropisms outside of the brain. 
Arrows (→) indicate neuronal morphology, and asterisks (*) designate pancreatic islets. 
Differences in brain transduction are depicted in the images of mouse brain sagittal sections. 
Figures 2A and 2D adapted from [53], and figures 2B–C adapted from [41].
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Figure 2. 
Clearing techniques that enable high-resolution, volumetric imaging of tissue architecture 
and cellular morphology. Whole-body hydrogel embedding and detergent-based clearing via 
the PARS-CLARITY method [22,32,37,41] preserves gross tissue structure (A) and fine 
neuronal processes (B) alike, while the purposeful expansion of these tissue-hydrogel 
hybrids via water absorption (C) allows the visualization of subcellular detail via either 
native fluorescence (D), or probes for protein and nucleic acid detection [32]. ePACT 
permits the clearing and 4-fold expansion of 100 µm thick coronal brain sections with 
preservation of tissue shape, cellular morphology and native fluorescence. Figures 1A–B 
adapted from [32], and figures 1C–D adapted from [41].
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Table 1
Anticipated Biomedical Applications of Modern Clearing Techniques
Application Areas Cleared Tissue and Complementary Technologies
Assessing biodistribution of chemicals or biologicals; and 
screening
compound libraries [53,91,146–152]
Whole-body clearinga of rodents (embryos through aged adult; see Figure 
1)
Excised whole-organ delipidation through major blood vessels in larger
mammalian subjects (e.g. pigs, non-human primates) [101,153]
CREATE platform for viral vector screening in cleared samples (Fig. 1) [53]
Labeling and imaging through dense, complex tissues [154–
161]
Mapping discrete cellular niches (e.g. stem cells, tumors) 
[162–168]
PACT-deCAL [41], BABB [27,106] for bone
Clearing tissue biopsiesb and excised organs, or whole-body perfusion-
clearinga
in cancer models
3D–tracing long-range fiber bundles (e.g. vagus nerve); 
lineage-mapping
in neurodevelopment [169]
Viral or transgenic labeling technologies (e.g. Brainbow [7], TRIO [6], 
Confetti
[170], MAGIC markers [171]; Box 1) followed by whole-body clearing
Monitoring the progression of cell death and tissue damage 
(e.g. stroke,
infarcts), and the corresponding re-oxygenation [172,173]
Whole-organ or whole-body clearing
Perfusion labelling to counterstain intact vasculature and surrounding 
tissues
Tracking nerve/axon regeneration and de/re-myelination; 
examining
neuroplasticity at the synaptic level [28,115,174–180]
Whole-body perfusion-clearinga and perfusion-labelling, and PACT-deCAL 
[41] to
clear the vertebral column
Co-registration of array tomography [181,182], light and electron 
microscopy
datasets [8,73,161,183–187]
Spectrally resolving subcellular labels (e.g. single molecule 
transcripts)
within native tissue
Multiplexed labelling and/or sequential barcoding with FISH [120–122] and 
HCR
[127,128]; Neuronal positioning system (NPS) [8]
Hydrogel-embedding and expansion-clearing (ExM [72], ePACT [41])
Exploring topics in parasitology [188] and microbiology 
(e.g., biofilm
formation, microbe distribution within a niche [189–192], 
host interaction
with the microbiome [64,193])
Hydrogel-embedding of fragile samples’b, followed by gentle, passive 
whole-organ
clearing to maintain bacterial colonization
Extending the imaging depth range and resolution for 
optical coherence
tomography [194–197] and photoacoustic tomography 
[141–143,145,198–
205]
Future prospects for optically clearing living tissue with optical and/or 
contrast
clearing reagents (e.g. varying ratios of PEG-400, DMSO, and/or glycerol)
a
For whole-body clearing and perfusion-labeling methods, see [31,32,39,41], with detailed methods on PARS and perfusion-CUBIC in their 
respective Nature Protocols
b
For further advice, see troubleshooting instructions at http://www.nature.com/nprot/journal/v10/n11/fig_tab/nprot.2015.122_T5.html [41]
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Table 3
Sample mounting for enhanced optical clarity.
Methoda Sample Preparation Clearing Reagents Size Fluctuations Fluorescence
organic solvents
RI ~ 1.52–1.57
none methyl salicylate [209] shrinkage NO
Ultramicroscopy [27] BABB shrinkage Y/N»
3DISCO
iDISCO dibenzyl ether shrinkage Y/N
amides
RI ~ 1.38–1.44
ClearT, ClearT2 [24] formamide ± PEG none, n/db Y/N
Sca/eA2, Sca/eS, CUBIC, 
FRUIT urea slight -moderate expansion YES
polyol and concentrated sugar or
sugar alcohol solutions
RI ~ 1.43–1.50, tunable
CLARITY, PACT, PARS glycerol slight expansion YES
SeeDB [21,102] fructose minimal YES
FRUIT fructose + thioglycerol + 
urea
slight expansion YES
Sca/eA2 glycerol + urea moderate expansion YES
CUBIC sucrose + urea + triethanolamine moderate expansion YES
Sca/eS, PARS, PACT sorbitol, sRIMS slight - moderate expansion YES
aqueous contrast media
RI ~ 1.46, tunable
CLARITY Focus Clear:Diatrizoic acid slight expansion YES
PACT, PARS, RIMS RIMS: Histodenz acute shrinkage,gradual expansion YES
aqueous mounting media
RI ~ 1.33–1.52, tunable TDE [34] 2,2’-thiodiefhanol [83] none YES
aOptical clarity, or reduced light scattering through tissue, may be enhanced via homogenizing the refractive indices throughout heterogeneous 
tissues and at all material interfaces between the sample and objective lens
b
Y/N = signal decay may necessitate prompt imaging upon sample mounting
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